In this study, we found a novel mechanism by which glutamine metabolism activated PI3K/Akt/mTOR in ccRCC-the downregulation of GLUD1 in glutamine metabolism pathway. This evidence concerns the gene MTOR and nonpapillary renal cell carcinoma.